SCHEMBL7755982

SCHEMBL7755982

O=C(Cl)OC1CCCCCCCCCCC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.50
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
CYP2C19 P33261 1/20 0.44
NAAA Q02083 2/20 0.42
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP19A1 P11511 3/20 0.39
GPR35 Q9HC97 1/20 0.38
MMP9 P14780 2/20 0.38
MMP12 P39900 2/20 0.38
MMP1 P03956 1/20 0.38
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
FABP7 O15540 1/20 0.37
FABP5 Q01469 1/20 0.37
MMP2 P08253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12655400 1.00 EPHX1 (0.50) EPHX1CA12CA1CA2CA9
SCHEMBL14754151 1.00 EPHX1 (0.50) EPHX1CA12CA1CA2CA9
SCHEMBL9273496 1.00 EPHX1 (0.50) EPHX1CA12CA1CA2CA9
SCHEMBL19729046 1.00 EPHX1 (0.50) EPHX1CA12CA1CA2CA9
SCHEMBL31239306 1.00 EPHX1 (0.50) EPHX1CA12CA1CA2CA9
SCHEMBL5836570 1.00 EPHX1 (0.50) EPHX1CA12CA1CA2CA9
SCHEMBL82977 1.00 EPHX1 (0.50) EPHX1CA12CA1CA2CA9
SCHEMBL9270019 1.00 EPHX1 (0.50) EPHX1CA12CA1CA2CA9
SCHEMBL19729048 1.00 EPHX1 (0.50) EPHX1CA12CA1CA2CA9
SCHEMBL14873606 1.00 EPHX1 (0.50) EPHX1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3566719-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASES Cerulean Pharma Inc. (US) 2019-11-13 EP disclosed
US-20140328918-A1 METHODS OF TREATING A SUBJECT AND RELATED PARTICLES, POLYMERS AND COMPOSITIONS CERULEAN PHARMA INC. (US) 2014-11-06 US disclosed
EP-0850927-B1 Novel oxalic acid peroxide compositions and their uses ATOFINA CHEM INC (US) 2001-03-14 EP disclosed
EP-0610016-B2 1-Cyclohexyl-1-methylethylperoxy carbonates, method for production thereof, and uses therefor NOF CORP (JP) 1999-10-20 EP disclosed
US-5866712-A POLYMERIZATION AND CURING CATALYSTS ELF ATOCHEM NORTH AMERICA, INC. (US) 1999-02-02 US disclosed
EP-0850927-A1 Novel oxalic acid peroxide compositions and uses ELF ATOCHEM NORTH AMERICA, INC. (US) 1998-07-01 EP disclosed
US-5451654-A Addition polymerization catalyst ELF ATOCHEM NORTH AMERICA, INC. (US) 1995-09-19 US disclosed
US-5446191-A Polymerization initiator for vinyl monomer, curing agent for unsaturated polyester NOF CORPORATION (JP) 1995-08-29 US disclosed
US-5387654-A Hydroxy-peroxides and their uses ELF ATOCHEM NORTH AMERICA, INC. (US) 1995-02-07 US disclosed
EP-0610016-A1 1-Cyclohexyl-1-methylethylperoxy carbonates, method for production thereof, and uses therefor NOF CORPORATION (JP) 1994-08-10 EP disclosed
EP-0381135-B1 Novel hydroxy-peroxides and their uses ATOCHEM NORTH AMERICA (US) 1994-06-01 EP disclosed
US-5304649-A Curing agent for unsaturated polyesters ELF ATOCHEM NORTH AMERICA, INC. (US) 1994-04-19 US disclosed
EP-0381135-A2 Novel hydroxy-peroxides and their uses ATOCHEM NORTH AMERICA, INC. (US) 1990-08-08 EP disclosed
US-4515787-A Steroids ROUSSEL UCLAF (FR) 1985-05-07 US disclosed
US-4137252-A FREE RADICAL POLYMERIZATION CATALYST, CURING CATALYST NIPPON OIL AND FATS CO., LTD. (JP) 1979-01-30 US disclosed
US-4129704-A Polymerization of vinyl monomers employing a diperoxyester mixture composition prepared by reacting dihydroperoxide and peroxyester forming carbonyl compounds PENNWALT CORPORATION (US) 1978-12-12 US disclosed
US-4097408-A FROM DIHYDOPEROXIDE AND CARBONYL COMPOUND, POLYMERIZATION CATALYSTS PENNWALT CORPORATION (US) 1978-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140328918-A1 METHODS OF TREATING A SUBJECT AND RELATED PARTICLES, POLYMERS AND COMPOSITIONS HLA-DRB1, TSG101, IAPP EPHX1 2213/4885CA12 108/4885CA1 713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.